For laboratory research use only — not for human or veterinary consumption.
The Peptide Index
Dosing guide

GHRP-2 Dosage Chart & Schedule

A potent growth-hormone-releasing peptide and ghrelin-receptor agonist studied for stimulating GH release; also investigated as a diagnostic test of pituitary GH reserve.

Route
Subcutaneous
Frequency
1-3x daily
Half-life
Approximately 15–60 minutes
Storage
Refrigerate reconstituted; keep lyophilized vial cool and dark
The short answer

Research references commonly cite ~100-300 mcg per dose, 1-3x daily, often paired with a GHRH analog; a ~1 mcg/kg 'saturation dose' is a common reference point. Not established for general human use.

Figures describe how GHRP-2 is reported in the research literature and research-community references — not a recommendation for human use. For laboratory research only.

Dosage protocols

Commonly referenced research tiers. Start conservative; every compound and study context differs.

Starter
100 mcg
per injection
Frequency
1-2x daily
Weekly total
0.7-1.4 mg
Cycle
8-12 weeks, then reassess

A conservative entry near the referenced ~1 mcg/kg saturation dose, above which GH release shows diminishing returns.

Most commonStandard
200-300 mcg
per injection
Frequency
2-3x daily
Weekly total
2.8-6.3 mg
Cycle
8-12 weeks, then reassess

The most commonly referenced range, often paired with a GHRH analog; higher exposure can modestly raise cortisol and prolactin.

Saturation dose concept

  • Research references a ~1 mcg/kg saturation dose for GHRPs, above which additional peptide yields diminishing GH release.
  • Higher exposure can modestly raise cortisol and prolactin compared with ipamorelin.

Also a diagnostic agent

  • GHRP-2 (pralmorelin) has been studied and used as a diagnostic test of pituitary GH reserve, notably in Japan.
  • General human use is not established.

Ready to run this protocol?

Dosing is only as good as the vial. GHRP-2 is third-party tested with published COAs from our top-rated source — reconstitute with confidence and skip the guesswork on identity and purity.

Weekly schedule

A typical week on the standard protocol (2-3x daily).

Mon
Tue
Wed
Thu
Fri
Sat
Sun

Dosing day Off

GHRP-2 reconstitution

Based on a standard 10 mg vial: with 2 mL bacteriostatic water = 5,000 mcg/mL (5 mg/mL); 1 unit ≈ 50 mcg.

Concentration
5,000 mcg/mL
Per syringe unit
50 mcg
Draw for 200 mcg
4 units
Doses per vial
~50
Open this mix in the calculator →

From vial to injection in 6 steps

1

Wipe both vial tops

Swab the peptide vial and the bacteriostatic-water vial with fresh alcohol and let them dry.

2

Draw the water

Pull the planned amount of bacteriostatic water (2 mL) into the syringe.

3

Add it slowly

Run the water down the inside wall of the vial — don't blast the powder. Swirl gently; never shake.

4

Let it dissolve

Wait until the solution is fully clear, then refrigerate the vial.

5

Draw your dose

Pull the calculated units on a U-100 insulin syringe (~4 units for 200 mcg).

6

Store between uses

Keep the reconstituted vial refrigerated and use within its stable window.

Handling & storage

  • Reconstitute with bacteriostatic water (2 mL into a 10 mg vial = 5000 mcg/mL)
  • Refrigerate reconstituted; keep the lyophilized powder cool and dark
  • A 200 mcg dose draws to ~4 units on a U-100 insulin syringe

GHRP-2 dosing FAQ

How much GHRP-2 per dose?

Research references commonly cite ~100-300 mcg per dose, 1-3x daily, often paired with a GHRH analog. A ~1 mcg/kg saturation dose is a common reference point. Not established for general human use.

How is GHRP-2 reconstituted?

With bacteriostatic water. For example, 2 mL into a 10 mg vial = 5000 mcg/mL, so a 200 mcg dose is about 4 units on a U-100 syringe.

Is GHRP-2 stacked with CJC-1295 or ipamorelin?

A GHRP is commonly referenced alongside a GHRH analog such as CJC-1295 because they act on different receptors; GHRP-2 and ipamorelin are both ghrelin-receptor agonists and are not typically combined with each other.

Does GHRP-2 cause hunger?

It can raise appetite via the ghrelin receptor, though less strongly than GHRP-6. This is a commonly noted research effect.

Sources

Categories: Growth Hormone Secretagogues · Status: Research use only. This page is educational and for laboratory research use only; it is not medical advice.